✦ LIBER ✦

Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease: Comparison of Outcomes With Cardiac Surgery and Paclitaxel-Eluting Stents

✍ Scribed by Adrian P. Banning; Stephen Westaby; Marie-Claude Morice; A. Pieter Kappetein; Friedrich W. Mohr; Sergio Berti; Mattia Glauber; Mirle A. Kellett; Robert S. Kramer; Katrin Leadley; Keith D. Dawkins; Patrick W. Serruys

Book ID: 119268728
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 743 KB
Volume: 55
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2009.09.057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Treatment of Coronary Artery D

Impact of Treatment of Coronary Artery Disease With Sirolimus-Eluting Stents on Outcomes of Diabetic and Nondiabetic Patients

✍ Pramod K. Kuchulakanti; Rebecca Torguson; Daniel Canos; Seung-Woon Rha; William 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Outcomes in Patients With Unprotected Le

Outcomes in Patients With Unprotected Left Main Coronary Disease: Comparison Between Drug-Eluting Stents and Coronary Artery By-Pass Grafting

✍ Messori, Andrea; Maratea, Dario; Fadda, Valeria; Trippoli, Sabrina 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Clinical and Angiographic Outcomes of Pa

Clinical and Angiographic Outcomes of Patients Treated With Everolimus-Eluting Stents or First-Generation Paclitaxel-Eluting Stents for Unprotected Left Main Disease

✍ Renato Valenti; Angela Migliorini; Guido Parodi; Nazario Carrabba; Ruben Vergara 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Long-Term Outcome of Stents Versus Bypas

Long-Term Outcome of Stents Versus Bypass Surgery in Diabetic and Nondiabetic Patients With Multivessel or Left Main Coronary Artery Disease: A Pooled Analysis of 5775 Individual Patient Data

✍ Park, D.-W.; Kim, Y.-H.; Song, H. G.; Ahn, J.-M.; Kim, W.-J.; Lee, J.-Y.; Kang, 📂 Article 📅 2012 🏛 Ovid Technologies Wolters Kluwer -American Heart A 🌐 English ⚖ 1001 KB

Comparison of Paclitaxel-Eluting Stents

Comparison of Paclitaxel-Eluting Stents (Taxus) and Everolimus-Eluting Stents (Xience) in Left Main Coronary Artery Disease With 3 Years Follow-Up (from the ESTROFA-LM Registry)

✍ De la Torre Hernandez, Jose M.; Alfonso, Fernando; Sanchez Recalde, Angel; Jimen 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Economic outcomes of percutaneous corona

Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial

✍ David J. Cohen; Tara A. Lavelle; Ben Van Hout; Haiyan Li; Yang Lei; Katherine Ro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

## Abstract Objectives: To evaluate the cost‐effectiveness of alternative approaches to revascularization for patients with three‐vessel or left main coronary artery disease (CAD). Background: Previous studies have demonstrated that, despite higher initial costs, long‐term costs with bypass surgery